These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4971419)

  • 21. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intra-arterial infusions in the treatment of obliterating diseases of the arteries of the lower limbs].
    Parakhoniak VI; Ovchinnikov VA; Mizinov KN
    Khirurgiia (Mosk); 1976 Nov; (11):104-8. PubMed ID: 1011564
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies].
    Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A
    Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709
    [No Abstract]   [Full Text] [Related]  

  • 24. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conservative treatment of the diabetic foot].
    Schena RA
    Prensa Med Argent; 1967 Jun; 54(16):736-41. PubMed ID: 4387178
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with bencyclane in peripheral disorders of arterial blood supply].
    Alánt O; Horváth N
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1403+. PubMed ID: 5536654
    [No Abstract]   [Full Text] [Related]  

  • 27. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. II. Effects of venous administration of papaverine hydrochloride].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1116-9. PubMed ID: 5992025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 32. [Conservative treatment of diabetic gangrene by means of continuous intra-arterial perfusion].
    Calvet JM
    Diabete; 1968 Sep; ():Suppl:62-7. PubMed ID: 5759340
    [No Abstract]   [Full Text] [Related]  

  • 33. Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
    Okuda Y; Mizutami M; Tanaka K; Isaka M; Yamashita K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):139-40. PubMed ID: 1478154
    [No Abstract]   [Full Text] [Related]  

  • 34. [OUR EXPERIENCE WITH INTERAARTERIAL THERAPEUTICS IN ARTERIOPATHIES OF THE LOWER EXTREMITIES].
    KITAINIK E; CUNEO JL; SWIATLO MR; BREYTER E; QUINTANA C
    Sem Med; 1964 Jan; 124():333-6. PubMed ID: 14129176
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
    [No Abstract]   [Full Text] [Related]  

  • 36. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 37. Chelation endarterectomy for occlusive atherosclerosis.
    Lamar CP
    J Am Geriatr Soc; 1966 Mar; 14(3):272-94. PubMed ID: 4956088
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of diabetic gangrene].
    Kasperska-Czyzykowa T; Olszewski A
    Pol Tyg Lek; 1974 Jul; 29(27):1161-3. PubMed ID: 4846883
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood serum lipoproteins in patients with diabetic angiopathy and obliterating atherosclerosis].
    Mazovetskiĭ AG; Podtergeria VG; De la Vara F
    Ter Arkh; 1969 Sep; 41(9):63-6. PubMed ID: 5396453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.